Deadly new Covid variant sweeps across Europe—are we heading for another lockdown?
A fresh wave of Covid-19 concern has swept across Europe as a new variant, known as XEC, gains ground, showing signs of becoming the dominant ... Read More
COVID strikes back: Is the world prepared for the EG.5 onslaught?
Just when the world was breathing a sigh of relief, COVID-19's new and aggressive EG.5 variant is making headlines. The recent surge, particularly gripping the ... Read More
Gennova’s GEMCOVAC-OM Omicron-specific mRNA-based booster vaccine gets EUA in India
The Department of Biotechnology (DBT), part of the Indian Ministry of Science & Technology, has revealed that the Omicron-specific mRNA-based booster vaccine, developed by Pune-based ... Read More
Everest Medicines commissions mRNA vaccine production plant in Jiashan
Everest Medicines, a China-based biopharmaceutical company, has commenced operations at its mRNA vaccine production plant in Jiashan, Zhejiang Province, thereby becoming a fully-integrated biopharma. With ... Read More
FDA grants EUA for Omicron-adapted Covid-19 vaccine for children below five
Pfizer and BioNTech have received the US Food and Drug Administration (FDA) emergency use authorization (EUA) for their Omicron BA.4/BA.5-adapted bivalent Covid-19 vaccine for children ... Read More
Lilly gets FDA EUA for bebtelovimab in mild-to-moderate Covid-19
Eli Lilly and Company (Lilly) has secured Emergency Use Authorization (EUA) from the US Food and Drug Administration (FDA) for bebtelovimab for the treatment of ... Read More
Celltrion files IND for phase 3 trial of inhaled Covid-19 cocktail therapy
Celltrion Group (Celltrion Healthcare), a South Korean pharma company, has submitted an investigational new drug (IND) application to carry out a global phase 3 clinical ... Read More
Regeneron says REGEN-COV monoclonal antibodies active against Omicron, Delta and other variants
Regeneron Pharmaceuticals said that the monoclonal antibodies of its REGEN-COV cocktail are active against all known variants of concern of Covid-19, including Omicron and Delta. ... Read More